Cineplex Inc. (TSE:CGX) Director Sarabjit Marwah Sells 1,500 Shares

Cineplex Inc. (TSE:CGXGet Free Report) Director Sarabjit Marwah sold 1,500 shares of the company’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of C$12.27, for a total value of C$18,405.00.

Cineplex Trading Down 0.6 %

Cineplex stock opened at C$12.45 on Wednesday. The company has a debt-to-equity ratio of 30,533.69, a quick ratio of 0.22 and a current ratio of 0.36. The stock has a market cap of C$792.82 million, a PE ratio of -11.12, a price-to-earnings-growth ratio of 0.30 and a beta of 2.74. The stock has a 50-day moving average of C$11.04 and a two-hundred day moving average of C$9.98. Cineplex Inc. has a one year low of C$7.10 and a one year high of C$13.09.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group boosted their target price on shares of Cineplex from C$11.50 to C$12.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cineplex currently has an average rating of “Moderate Buy” and an average target price of C$18.71.

View Our Latest Research Report on Cineplex

Cineplex Company Profile

(Get Free Report)

Cineplex Inc, together with its subsidiaries, operates as an entertainment and media company in Canada and internationally. It operates through three segments: Film Entertainment and Content, Media, and Location-Based Entertainment. The company engages in theatre exhibitions and food service activities; and provision of alternative programming service comprising international film programming, as well as content offered under the Event Cinema brand, including The Metropolitan Opera, sporting events, concerts, and dedicated event screens.

Featured Articles

Receive News & Ratings for Cineplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cineplex and related companies with MarketBeat.com's FREE daily email newsletter.